Sulfasalazine and Drug administration error - a phase IV clinical study of FDA data

Summary:

Drug administration error is reported as a side effect among people who take Sulfasalazine (sulfasalazine), especially for people who are female, 60+ old, also take Enbrel, and have Osteopenia.

The phase IV clinical study analyzes which people have Drug administration error when taking Sulfasalazine. It is created by eHealthMe based on reports of 95,646 people who have side effects when taking Sulfasalazine from the FDA, and is updated regularly.

What is Sulfasalazine?

Sulfasalazine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 96,787 Sulfasalazine users. Check the latest studies of Sulfasalazine.

What is Drug administration error?

Drug administration error is found to be associated with 1,021 drugs and 1,483 conditions by eHealthMe. Check the latest studies of Drug administration error.

On Jul, 06, 2026

95,646 people reported to have side effects when taking Sulfasalazine.
Among them, 24 people (0.03%) have Drug administration error.

Could Sulfasalazine cause Drug administration error?

Among these 24 people:

What is the gender of people who have Drug administration error when taking Sulfasalazine? *

female: 68.18 %
male: 31.82 %

What is the age of people who have Drug administration error when taking Sulfasalazine? *

What are other drugs people take besides Sulfasalazine? *

What are other side effects people have besides Drug administration error? *

Dyspnea (difficult or laboured breathing): 7 people, 29.17%
Insomnia (sleeplessness): 7 people, 29.17%
Weight Increased: 6 people, 25.00%
Restless Leg Syndrome (a powerful urge to move your legs): 6 people, 25.00%
Low Turnover Osteopathy (slow removal of old bone and its replacement by new bone): 6 people, 25.00%
Memory Loss: 6 people, 25.00%
Depression: 6 people, 25.00%
Cough: 6 people, 25.00%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 6 people, 25.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 25.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 25.00%
Osteopenia (a condition where bone mineral density is lower than normal): 6 people, 25.00%
Allergic Rhinitis: 2 people, 8.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 8.33%
Osteomyelitis (infection of bone): 2 people, 8.33%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 8.33%
Sleep Disorder: 2 people, 8.33%
Diabetes: 2 people, 8.33%
High Blood Cholesterol: 2 people, 8.33%
Gastric Disorder (disease of stomach): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfasalazine and have Drug administration error?

- Check whether Drug administration error is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sulfasalazine:

Sulfasalazine (96,787 reports)

Browse all side effects of Sulfasalazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug administration error:

Drug administration error (1,021 drugs)

Browse all the conditions that are associated with Drug administration error:

Drug administration error (1,483 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Sulfasalazine) and Sulfasalazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.